These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 23592243)

  • 21. Investigating Nrg1 Signaling in the Regenerating Axolotl Spinal Cord Using Multiplexed FISH.
    Freitas PD; Lovely AM; Monaghan JR
    Dev Neurobiol; 2019 May; 79(5):453-467. PubMed ID: 30793850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of oligodendrocyte myelin glycoprotein and its receptor NgR after the injury of rat central nervous system.
    Guo Q; Li S; Su B
    Neurosci Lett; 2007 Jul; 422(2):103-8. PubMed ID: 17630211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nogo on the go.
    McKerracher L; Winton MJ
    Neuron; 2002 Oct; 36(3):345-8. PubMed ID: 12408839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of growth factors and soluble Nogo-66 receptor protein on transplanted neural stem/progenitor survival and axonal regeneration after complete transection of rat spinal cord.
    Guo X; Zahir T; Mothe A; Shoichet MS; Morshead CM; Katayama Y; Tator CH
    Cell Transplant; 2012; 21(6):1177-97. PubMed ID: 22236767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular approaches to spinal cord repair.
    David S; Lacroix S
    Annu Rev Neurosci; 2003; 26():411-40. PubMed ID: 12626698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myelin-associated glycoprotein interacts with the Nogo66 receptor to inhibit neurite outgrowth.
    Domeniconi M; Cao Z; Spencer T; Sivasankaran R; Wang K; Nikulina E; Kimura N; Cai H; Deng K; Gao Y; He Z; Filbin M
    Neuron; 2002 Jul; 35(2):283-90. PubMed ID: 12160746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Resistance of interleukin-6 to the extracellular inhibitory environment promotes axonal regeneration and functional recovery following spinal cord injury.
    Yang G; Tang WY
    Int J Mol Med; 2017 Feb; 39(2):437-445. PubMed ID: 28075461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Nogo-66 receptor: focusing myelin inhibition of axon regeneration.
    McGee AW; Strittmatter SM
    Trends Neurosci; 2003 Apr; 26(4):193-8. PubMed ID: 12689770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Receptors for myelin inhibitors: Structures and therapeutic opportunities.
    Cao Z; Gao Y; Deng K; Williams G; Doherty P; Walsh FS
    Mol Cell Neurosci; 2010 Jan; 43(1):1-14. PubMed ID: 19619659
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structural features of the Nogo receptor signaling complexes at the neuron/myelin interface.
    Saha N; Kolev M; Nikolov DB
    Neurosci Res; 2014 Oct; 87():1-7. PubMed ID: 24956133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunization with recombinant Nogo-66 receptor (NgR) promotes axonal regeneration and recovery of function after spinal cord injury in rats.
    Yu P; Huang L; Zou J; Yu Z; Wang Y; Wang X; Xu L; Liu X; Xu XM; Lu PH
    Neurobiol Dis; 2008 Dec; 32(3):535-42. PubMed ID: 18930141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effects of Jisuikang on Nogo-NgR gene expression in spinal cord rats with injury].
    You WL; Zhang YF; Chen JF; Yin H; Yang JF; Wang JW
    Zhongguo Gu Shang; 2015 Mar; 28(3):235-9. PubMed ID: 25936193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myelin-associated glycoprotein-mediated signaling in central nervous system pathophysiology.
    Chen Y; Aulia S; Tang BL
    Mol Neurobiol; 2006 Oct; 34(2):81-91. PubMed ID: 17220531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo.
    Zheng B; Atwal J; Ho C; Case L; He XL; Garcia KC; Steward O; Tessier-Lavigne M
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1205-10. PubMed ID: 15647357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nogo in the injured spinal cord.
    Schweigreiter R; Bandtlow CE
    J Neurotrauma; 2006; 23(3-4):384-96. PubMed ID: 16629624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined genetic attenuation of myelin and semaphorin-mediated growth inhibition is insufficient to promote serotonergic axon regeneration.
    Lee JK; Chow R; Xie F; Chow SY; Tolentino KE; Zheng B
    J Neurosci; 2010 Aug; 30(32):10899-904. PubMed ID: 20702718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunization with myelin or recombinant Nogo-66/MAG in alum promotes axon regeneration and sprouting after corticospinal tract lesions in the spinal cord.
    Sicotte M; Tsatas O; Jeong SY; Cai CQ; He Z; David S
    Mol Cell Neurosci; 2003 Jun; 23(2):251-63. PubMed ID: 12812757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salamander spinal cord regeneration: The ultimate positive control in vertebrate spinal cord regeneration.
    Tazaki A; Tanaka EM; Fei JF
    Dev Biol; 2017 Dec; 432(1):63-71. PubMed ID: 29030146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LOTUS suppresses axon growth inhibition by blocking interaction between Nogo receptor-1 and all four types of its ligand.
    Kurihara Y; Iketani M; Ito H; Nishiyama K; Sakakibara Y; Goshima Y; Takei K
    Mol Cell Neurosci; 2014 Jul; 61():211-8. PubMed ID: 25034269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nogo and axon regeneration.
    Schwab ME
    Curr Opin Neurobiol; 2004 Feb; 14(1):118-24. PubMed ID: 15018947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.